Dravet syndrome: from electroclinical characteristics to molecular biology
- PMID: 19702726
- DOI: 10.1111/j.1528-1167.2009.02228.x
Dravet syndrome: from electroclinical characteristics to molecular biology
Abstract
The onset of Dravet syndrome typically occurs within the first year, with prolonged, generalized, or unilateral clonic seizures triggered by fever. In the early stages, other types of refractory seizures usually present that include myoclonic seizures, atypical absences, and partial seizures. Electroencephalography (EEG) findings are not pathognomonic, and signs of cognitive arrest or deterioration progressively appear. In contrast, in adults, myoclonic seizures, atypical absences, and focal seizures tend to disappear, and short tonic-clonic seizures, often associating a focal component, persist particularly during sleep. The sensitivity to fever persists into adulthood, and although mental deterioration occurs in infancy, usually leaving patients with severe mental impairment, further deterioration does not occur. The identification of genes associated with Dravet syndrome and related syndromes hints at the complexity of the etiology of such epilepsies. Identifying SCN1A mutations has become useful as a means to support an early diagnosis of Dravet syndrome, to benefit counseling, and to avoid use of antiepileptic drugs (AEDs) that may have adverse effects. However, the defining characteristics of seizure type and EEG patterns initially identified by Dravet remain fundamental to diagnosis.
Similar articles
-
The core Dravet syndrome phenotype.Epilepsia. 2011 Apr;52 Suppl 2:3-9. doi: 10.1111/j.1528-1167.2011.02994.x. Epilepsia. 2011. PMID: 21463272 Review.
-
Dravet syndrome: a technologist's perspective.Am J Electroneurodiagnostic Technol. 2010 Dec;50(4):297-312. Am J Electroneurodiagnostic Technol. 2010. PMID: 21313790
-
[Clinical and genetic diagnosis of Dravet syndrome: report of 20 cases].Ideggyogy Sz. 2008 Nov 30;61(11-12):402-8. Ideggyogy Sz. 2008. PMID: 19070316 Hungarian.
-
Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults.Neurology. 2006 Dec 26;67(12):2224-6. doi: 10.1212/01.wnl.0000249312.73155.7d. Neurology. 2006. PMID: 17190949
-
Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies.Epilepsy Res. 2006 Aug;70 Suppl 1:S223-30. doi: 10.1016/j.eplepsyres.2006.01.019. Epub 2006 Jun 27. Epilepsy Res. 2006. PMID: 16806826 Review.
Cited by
-
The psychosocial impact of caring for children with Dravet Syndrome.Epilepsy Behav Rep. 2023 Aug 25;24:100619. doi: 10.1016/j.ebr.2023.100619. eCollection 2023. Epilepsy Behav Rep. 2023. PMID: 37701518 Free PMC article.
-
PRRT2-positive self-limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers.Epilepsia Open. 2023 Jun;8(2):436-443. doi: 10.1002/epi4.12708. Epub 2023 Feb 20. Epilepsia Open. 2023. PMID: 36775847 Free PMC article.
-
Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe.Epilepsia Open. 2022 Mar;7(1):11-26. doi: 10.1002/epi4.12569. Epub 2021 Dec 19. Epilepsia Open. 2022. PMID: 34882995 Free PMC article. Review.
-
An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies.Int J Mol Sci. 2021 Aug 5;22(16):8416. doi: 10.3390/ijms22168416. Int J Mol Sci. 2021. PMID: 34445144 Free PMC article. Review.
-
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety.CNS Drugs. 2020 Mar;34(3):229-241. doi: 10.1007/s40263-020-00708-6. CNS Drugs. 2020. PMID: 32040850
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical